Boehringer Ingelheim and Lilly expand heart failure programme for empag
EMPERIAL clinical trials will evaluate the effect of empagliflozin on exerci...
2018-03-08
文传商讯
First dedicated outcome trials of empagliflozin in chronic heart failur
EMPEROR HF clinical trial programme will evaluate the efficacy and safety of...
2017-03-20
文传商讯
